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ABSTRACT Themechanism of the interaction between the cell-penetrating peptide transportan 10 (tp10) and phospholipid mem-
branes was investigated. Tp10 induces graded release of the contents of phospholipid vesicles. The kinetics of peptide as-
sociation with vesicles and peptide-induced dye efﬂux from the vesicle lumen were examined experimentally by stopped-ﬂow
ﬂuorescence. The experimental kinetics were analyzed by directly ﬁtting to the data the numerical solution of mathematical kinetic
models. A very good global ﬁt was obtained using amodel in which tp10 binds to themembrane surface and perturbs it because of
themass imbalance thus created across the bilayer. The perturbed bilayer state allows peptidemonomers to insert transiently into
its hydrophobic core and cross the membrane, until the peptide mass imbalance is dissipated. In that transient state tp10
‘‘catalyzes’’ dye efﬂux from the vesicle lumen. These conclusions are consistent with recent reports that usedmolecular dynamics
simulations to study the interactions between peptide antimicrobials and phospholipid bilayers. A thermodynamic analysis of tp10
binding and insertion in the bilayer using water-membrane transfer hydrophobicity scales is entirely consistent with the model
proposed. A small bilayer perturbation is both necessary and sufﬁcient to achieve very good agreement with the model, indicating
that the role of the lipids must be included to understand the mechanism of cell-penetrating and antimicrobial peptides.
INTRODUCTION
Cell-penetrating peptides (CPPs), also called protein trans-
duction domains, are a heterogeneous set of peptides that can
be broadly divided into two categories: highly cationic and
amphipathic. Most peptides investigated belong to the former
class. Common examples are penetratin (1), which is a 16-
amino acid segment derived for the Antennapedia homeo-
domain of Drosophila, the Tat peptides (2,3), derived from
the HIV-1 Tat protein, and simple polyarginine peptides
such as (Arg)6–8. The transportan 10 (tp10) (4,5) used in this
study belongs to the second class. Peptides in this class are
similar to antimicrobial (6) and cytolytic or cytotoxic
amphipathic peptides. Tp10 is a 21-residue peptide derived
from mastoparan, a 14-residue peptide from wasp (Vespula
lewisii) venom, linked, in a chimeric construct, to a 6-residue
sequence from the neuropeptide galanin through an extra
lysine residue. Tp10 has been shown to transport cargo across
cell membranes (5). The parent transportan, which is slightly
longer than tp10, has been reported to transport even larger
molecules, such as green ﬂuorescent protein, attached to the
peptide by a biotinyl linkage (7). Neither tp10 nor transportan
function as ligands for the galanin receptor (4), suggesting
that a direct interaction with the lipid bilayer is involved.
Transportan (8) and mastoparan X (9,10), which is very
similar to the V. lewisiimastoparan used in constructing tp10,
form amphipathic a-helices when bound to membranes.
Therefore, it is very likely that tp10 will also form an a-helix
under those conditions. A helical wheel projection of tp10
is shown in Fig. 1. Tp10 contains a high proportion of pos-
itively charged amino acids, four lysines, and the N-terminus,
and no negative charges, imparting it with a formal 15
charge at neutral pH. This charge is large for antimicrobial
peptides on a per residue basis. For comparison with some of
the best studied amphipathic a-helical antimicrobials, cecro-
pin A (11,12) has a 17 charge but 37 residues, magainin-2
(13) has a13 charge and 23 residues, and dermaseptin-1 (14)
has a14 charge and 34 residues. Tp10 clearly has the highest
charge density of these four peptides. This high charge is a
feature in common with the polycationic CPPs. However, in
cationic CPPs arginine is more efﬁcient as the basic amino
acid than lysine (15). Tp10 contains no arginine but only
lysine, which is a common feature of most amphipathic,
a-helical, antimicrobial peptides (6).
The mechanism of cell penetration by CPPs was originally
believed to be a passive permeation through cell membranes—
however unlikely that might have seemed for such highly
charged molecules—but more recently most investigators
seem to favor the idea that the initial crossing of the plasma
membrane occurs by endocytosis. Nevertheless, the problem
still remains of how the CPPs exit the endocytic vesicle into
the cytoplasm. This has not been resolved. Even the require-
ment for endocytosis is questionable at this point: many
highly charged peptides, especially those rich in arginine,
appear to be able to cross hydrophobic media such as
bilayers, if these contain anionic lipids or amphiphiles (16).
Less clear still is the situation for amphipathic a-helical
peptides, antimicrobial or not. d-Lysin, a 26-residue,
amphipathic, a-helical peptide from Staphylococcus aureus,
was recently proposed to cause dye efﬂux from phospholipid
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vesicles by disturbing the membrane, as it crosses the bilayer
in the form of a small aggregate, probably a trimer (17,18).
This was suggested to occur by a perturbation of the bilayer
in the form of a mass imbalance caused directly by the
peptide binding to the outer leaﬂet, possibly resulting in local
curvature strain. This perturbation would allow small peptide
aggregates to sink deeply into the bilayer and cross it—the
so-called ‘sinking raft’ model (17–19).
Here, a detailed and quantitative analysis of the interaction
of tp10 with large unilamellar vesicles (LUVs) of zwitterionic
lipids (phosphatidylcholine, PC) and mixtures of PC and the
anionic lipid phosphatidylserine (PS) was performed to gain a
better understanding of the uptake mechanism of tp10. The
experimental data on the kinetics of peptide association with
lipid vesicles and the release of encapsulated ﬂuorophores
induced by tp10 are consistent with a very simple model. We
propose that, similar to d-lysin, tp10 ﬁrst associates with the
outer leaﬂet of the bilayer and, by doing so, creates a mass
imbalance that disturbs the membrane. We have no evidence
for tp10 aggregation. Any cooperative effects appear to be
mediated by the lipid: the larger themass imbalance, the larger
the bilayer perturbation. At some point, the tp10 peptides
simply cross the bilayer, allowing efﬂux of entrapped dye to
occur concomitant with that process. The results are discussed
in light of recent molecular dynamics simulations (20–22),
which show antimicrobials crossing a bilayer by a very similar
mechanism. The likelihood of this mechanism is assessed
based on thermodynamic calculations of peptide transfer, ﬁrst
to the bilayer interface and then to its hydrophobic core, using
the approach of White and Wimley (23).
MATERIALS AND METHODS
Chemicals
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmito-
yl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) in chloroform solution were
purchased from Avanti Polar Lipids (Alabaster, AL). 8-Aminonaphtalene-
1,3,6-trisulfonic acid, disodium salt (ANTS) and p-xylene-bis-pyridinium
bromide (DPX) were purchased from Molecular Probes/Invitrogen (Carls-
bad, CA). Carboxyﬂuorescein (99% pure, lot A015252901) was purchased
from ACROS (Morris Plains, NJ). 7-Methoxycoumarin-4-acetic acid was
from Sigma-Aldrich (St. Louis, MO). Anisole was purchased from Aldrich
and thioanisole fromAlfa Aesar (Ward Hill, MA). Triﬂuoroacetic acid (TFA)
was from Mallenckrodt (Phillipsburg, NJ). Organic solvents (high-perfor-
mance liquid chromatography (HPLC)/American Chemical Society (ACS)
grade) were purchased from Burdick & Jackson (Muskegon, MI). Lipids and
probes were tested by thin-layer chromatography and used without further
puriﬁcation. Amino acids and activators used in the preparation of the ﬁrst
batch of tp10 were purchased from Neosystems (Strasbourg, France). Fmoc-
protected amino acids and resins used in the second batch of tp10 were
obtained from EMD Biosciences (San Diego, CA).
Preparation of tp10
Standard tp10 (AGYLLGKINLKALAALAKKIL-amide) was synthesized
using solid-state synthesis, as described before (4). For the ﬂuorescent
derivatives, the backbone of tp10 was synthesized in a 0.1-mmol scale on an
Applied Biosystems (Foster City, CA) Model 431A peptide synthesizer on
solid support, using dicyclohexyl-carbodiimide (DCC)/hydroxybenzotria-
zole (HOBt) activation strategy. Standard t-Boc amino acids were coupled as
HOBt esters to a p-methylbenzylhydrylamine (MBHA) resin to obtain
C-terminal amidation. At position Lys-7 we used t-bocLys (Fmoc) to be able
to selectively label the amino group at the side chain. After the synthesis the
Fmoc group was removed with 10% piperidine, and three equivalents of
7-methoxycoumarin-4-acetic acid were coupled manually using HOBt- and
o-benzotriazole-1-yl-N,N,N9,N9-tetramethyluronium tetraﬂuorborate (TBTU).
This coupling procedure was repeated three times. The peptide was then
cleaved from the resin with hydrogen ﬂuoride using 10% paracreosol as
scavenger (30 min, 0C), extracted with ether, and lyophilized. From the
crude product both 7-methoxycoumarin-tp10 (tp10-7mc) and unlabeled tp10
could be isolated by preparative HPLC in roughly equal amounts. Both
products were further puriﬁed by semipreparative HPLC. The purity of the
peptides was .99% as checked by HPLC analysis on Nucleosil 1203 C18
column (0.4 cm 3 10 cm). The molecular mass of each peptide was deter-
mined on a matrix-assisted laser desorption ionization-time of ﬂight mass
spectrometer (Voyager STR, Applied Biosystems, Foster City, CA).
An additional batch of tp10 was synthesized, also by solid phase Fmoc
chemistry, on a 0.1-mmol scale using a PS3 Peptide Synthesizer (Protein Tech-
nologies, Tucson, AZ). Double couplings were used for leucine, isoleucine,
valine, and tyrosine. Peptide cleavage and removal of side-chain protecting
groupswas achievedby stirring 10mLTFA, 0.5mLwater, 0.5mLanisole, and
0.5mL thioanisole at room temperature for 2 h.After precipitationwithmethyl-
tert-butyl ether (OmniSolv, EMD Biosciences, San Diego, CA), the peptide
was dissolved in 10mL of 10% acetic acid. The peptides were then puriﬁed by
reversed-phase HPLC on a C18 column (Vydac, Hesperia, CA) with an
acetonitrile/water gradient (25%–50% acetonitrile over 50 min) with 0.1%
TFA and lyophilized. Peptide purity and mass was conﬁrmed with electro-
spray-ionization time-of-ﬂight mass spectrometry.
Preparation of large unilamellar vesicles
LUVs were prepared by mixing the appropriate lipid amounts in chloroform
in a round-bottom ﬂask. The solvent was rapidly evaporated using a rotary
evaporator (Bu¨chi R-3000, Flawil, Switzerland) at 60C–70C. The lipid
ﬁlm was then placed under vacuum for 4–8 h and hydrated by the addition of
buffer containing 20 mM MOPS (3-(N-morpholino)propanesulfonic acid),
FIGURE 1 Helical wheel projection of Tp10 generated using the program
MembraneProtein Explorer (44). Black symbols represent positively charged
residues, white, hydrophobic residues, dark gray, hydrophilic (uncharged),
and light gray, residues with intermediate polarity. The C-terminus is
amidated; therefore it carries no charge.
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pH 7.5, 0.1 mM EGTA, 0.02% NaN3, and 100 mM KCl or appropriately
modiﬁed as indicated below. The suspension of multilamellar vesicles was
subjected to ﬁve freeze-thaw cycles to increase the degree of dye (carboxy-
ﬂuorescein (CF) or ANTS/DPX) encapsulation. The suspension was then
extruded 10 times through two stacked Nuclepore polycarbonate ﬁlters
(Whatman, Florham, NJ) of 0.1-mm pore size, using a water-jacketed high
pressure extruder from Lipex Biomembranes (Vancouver, Canada) at room
temperature. Lipid concentrations were assayed by the Bartlett phosphate
method (24), modiﬁed as previously described (17), with the absorbance read at
580 nm.
Kinetics of tp10/bilayer association
The kinetics of association of tp10-7mc with LUVs of POPC and POPS/
POPC 2:8, as a function of lipid concentration, were recorded in a Applied
Photophysics (Leatherhead, Surrey, UK) SX.18MV stopped-ﬂow ﬂuorim-
eter. The excitation was at 350 nm and the emission was recorded through a
long-pass ﬁlter GG 385 (Edmund Industrial Optics, Barrington, NJ). The
emission maximum of tp10-7mc (as that of the ﬂuorophore itself) is 396 nm.
The peptide concentration was 0.5 mM (after mixing). Lipid concentrations
varied between 5 and 400 mM (after mixing).
ANTS/DPX assay
Steady-state ﬂuorescence measurements were performed in an SLM-
Aminco 8100 spectroﬂuorimeter (Urbana, IL). In the ANTS/DPX assay,
which was performed as described in detail by Ladokhin et al. (25) and
Ladokhin et al. (26), excitation was at 365 nm (8 nm slitwidth) and emission
was at 515 nm (16 nm slitwidth). The solution encapsulated in the LUVs
contained ANTS/DPX (5 mM each), 20 mM MOPS, pH 7.5, 0.1 mM
EGTA, 0.02% NaN3, and 70 mM KCl. The titrating solution contained 45
mMDPX, 20 mMMOPS, pH 7.5, 0.1 mMEGTA, 0.02%NaN3, and 30 mM
KCl. After extrusion, the LUVs with encapsulated ANTS and DPX were
passed through a Sephadex-G25 column to separate the dye in the external
buffer from the vesicles.
Carboxyﬂuorescein efﬂux experiments
LUVs for CF efﬂux kinetics measurements where prepared by hydration of
the lipid ﬁlm in 20 mM MOPS buffer, pH 7.5, containing 0.1 mM EGTA,
0.02% NaN3, and 50 mM CF, to give a ﬁnal lipid concentration of 10 mM.
For ﬂuorescence measurements, the suspension was diluted to the desired
lipid concentration in buffer containing 20 mM MOPS, pH 7.5, 100 mM
KCl, 0.1 mMEGTA, and 0.02%NaN3, which has the same osmolarity as the
CF-containing buffer. After extrusion, ﬂuorophore-containing LUVs were
passed through a Sephadex-G25 column to separate the dye in the external
buffer from the vesicles. The kinetics of carboxyﬂuorescein efﬂux, measured
by the relief of self-quenching of CF ﬂuorescence, was recorded in a Applied
Photophysics SX.18MV stopped-ﬂow ﬂuorimeter. The excitation was at 470
nm and the emission was recorded through a long-pass ﬁlter GG 530
(Edmund Industrial Optics). The peptide concentration was 0.5 mM in all
experiments. The ﬁnal fraction of CF release was determined by comparison
of the ﬂuorescence with that obtained by addition of Triton-X-100, which
dissolves the vesicles and releases all the dye.
Theoretical models and analysis of dye
efﬂux kinetics
The association and dissociation kinetics of tp10 monomers in aqueous
solution with lipid vesicles can be described by the scheme,
Mw1 L 
koff
kon
M
o
L; (1)
where Mw are tp10 monomers in water, L represents lipid vesicles, and M
o
L
represent monomers bound to the outer leaﬂet of the membrane. The
corresponding differential equations,
dMw
dt
¼ konMw½L1 koffMoL (2)
dM
o
L
dt
¼ konMw½L  koffMoL; (3)
have the solution
MwðtÞ ¼ expðkapptÞ; (4)
where
kapp ¼ kon½L1 koff : (5)
In these equations, [L] is the vesicle concentration, but it will always be
expressed in terms of lipid concentration (1 LUV ’ 105 lipids). Because the
number of peptides bound per vesicle is always small and vesicles do not
disappear when peptides bind, [L] is considered constant in the calculations.
The experimental data of CF efﬂux kinetics were analyzed with the
model depicted in Fig. 2. This is similar to the model used for d-lysin (18)
but simpler because only monomers are involved. In this model, the peptides
bind to the membrane surface and the increased mass of the outer leaﬂet
results in bilayer perturbation, possibly through local curvature strain. This
strain is relieved by the peptides inserting into and crossing the bilayer, after
which those that crossed remain mostly associated with the inner leaﬂet of
the bilayer. That is, desorption from the inner leaﬂet into the vesicle interior
is not included in the scheme because of the comparatively small magnitudes
of the off-rate constants. The translocation process continues until the concen-
trations of the peptide on both sides of the membrane are approximately
equal. The efﬂux of CF is in this way ‘catalyzed’ by the inserted peptide
state, which corresponds to the largest bilayer perturbation.
This model was translated into a set of coupled differential equations,
which constitute the kinetic model. The following scheme involves only
tp10 monomers but was appropriately modiﬁed to include possible
aggregates in other variants. In these equations, MoL and M
i
L represent
monomers bound to the outer and inner leaﬂets of the bilayer, respectively,
and MmL represent tp10 monomers inserted into the hydrophobic core of the
membrane. According to the model, this species correlates with dye efﬂux,
induced transiently as the peptide monomer crosses the bilayer (Eq. 9).
Membrane species:
dM
o
L
dt
¼ konMwL koffMoL  kinsMoL1 kdinsMmL (6)
dM
m
L
dt
¼ kinsðMoL1MiLÞ  2 kdinsMmL (7)
dM
i
L
dt
¼ kinsMiL1 kdinsMmL (8)
Carboxyﬂuorescein efﬂux:
dCFout
dt
¼ keflxð1 CFoutÞMmL =ðvoLÞ (9)
The apparent rate ‘constant’ for insertion kins depends on the difference in
the concentrations of peptide bound to the outer and inner leaﬂets of the lipid
bilayer,
kins ¼ kins3 j½Pouter  ½Pinnerj; (10)
where [P]outer and [P]inner are the concentrations, on the membrane, of
peptides bound to the outer and inner leaﬂets of the bilayer. Unlike kins, the
rate constant k*ins is a true constant. The rate constant for the reverse of insertion
is kdins. All concentrations of peptide species indicated by expressions of the
typeMx, whether referring to solution species ormembrane-bound species, are
expressed relative to the total aqueous solution volume.The factor vo¼ 0.6/2 is
about half the speciﬁc molar volume of the hydrophobic portion of a lipid
(;0.6M1), assumedof’15 A˚370 A˚2.Division by2 corrects [L] for the two
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leaﬂets of the lipid bilayer. For example, the concentration of boundmonomer
relative to the lipid is mo ¼ Mo/(voL), Mo being its concentration relative to
water. The peptide concentrations indicated by expressions of the type [P]x are
expressed relative to the lipid, not to water.
For the reverse experiment, an additional block of equations was added,
corresponding to the initial state in the donor vesicles preequilibrated with
tp10. This block is similar to the block corresponding to tp10 association to
vesicles (Eqs. 6–8 above). The initial conditions were calculated, from the
integrated equations in the forward reaction setting the time to 1 h, which
was the preincubation time of tp10 with empty vesicles.
Twomechanisms can be envisaged for the release of dye from the vesicles,
graded or all-or-none (25,26). Because in the graded mechanism partially
empty vesicles also contribute to the ﬂuorescence, especially at later times,
the theoretical kinetic curves of carboxyﬂuorescein efﬂux were corrected for
this effect as described in detail before (18). This correction changes the
calculated curves slightly, with minor effects on the ﬁt parameters.
The sets of differential equations describing the model were solved by
numerical integration with a ﬁfth-order Runge-Kutta method with constant
step size (27). The numerical solution was ﬁt directly to the experimental data
with a simplex algorithm (27). In the analysis of carboxyﬂuorescein efﬂux,
the on-rate constants, kon, obtained for the binding kinetics, were used as
ﬁxed parameters. The off-rate constants, koff, were allowed to vary because of
great uncertainty in their determination from the intercept of the plot of the
apparent rate constant against lipid concentration in the binding kinetics. Of
the remaining four rate constants (including koff), only three were allowed to
vary because keﬂx and kdins show a very large mutual correlation effect. We
thus ﬁxed keﬂx at an average value. The other three constants, koff, kins, and
kdins, were adjusted by a global ﬁt to all data sets of different lipid
compositions. This global ﬁt was performed in two stages. First, a simul-
taneous ﬁt to all data for POPC and POPC/POPS (separately) vesicles was
performed. Then, a 50% variation was allowed on each of the three constants
and the curveswereﬁt individually. Themean valuesof the individual ﬁtswere
then used as a new global ﬁt and the reﬁnement step was repeated. The ﬁnal
values are given in Table 1. In addition, an amplitude factor (0.75–1.2) was
allowed for each curve. This corrects for any experimental error in the
determination of the maximum dye release.
RESULTS
Tp10 aggregation in solution
Tp10 does not contain an intrinsic ﬂuorophore, such as
tryptophan. Therefore, tp10-7mc, a version of tp10 modiﬁed
with the ﬂuorophore 7-methoxycoumarin-4-acetic acid was
used to examine peptide aggregation in solution and the
kinetics of binding to membranes. In this tp10-7mc, the
ﬂuorophore is attached to the e-amino group of Lys-7 of tp10
through an amide bond to the acetic acid group of the cou-
marin. As shown in the next section, a decrease in ﬂuores-
cence intensity is observed when tp10-7mc binds to
membranes. For dilute solutions in which the peptides exist
as monomers, the ﬂuorescence intensity should be a linear
function of concentration. If the peptide concentration is
increased, the equilibrium between monomers and possible
aggregates will be shifted toward the aggregated state. The
ﬂuorescence intensity may then be expected to change if the
ﬂuorophore is exposed to a different environment as a
consequence of oligomerization or aggregation.
We ﬁnd that the intensity of ﬂuorescence emission of
7-methoxycoumarin at its maximum (396 nm) is a perfect
linear function of the tp10-7mc concentration between 0.04
and 40 mM (Fig. 3). This is consistent with the existence of
only one species of tp10-7mc in aqueous solution. Of course,
it does not prove that no aggregation takes place, because the
ﬂuorophore could be always exposed to water if small
oligomers occur. However, because tp10-7mc must almost
certainly be a monomer at the low end of the concentration
range examined (0.04 mM), it is probably monomeric
throughout this concentration range. It appears unlikely
that no ﬂuorescence change would occur upon oligomeriza-
tion because a decrease in coumarin ﬂuorescence does occur
upon binding to membranes, indicating that the ﬂuorophore
is sensitive to environment. In the next section we present
FIGURE 2 Scheme of the model for peptide-induced transient pore
formation and peptide translocation across the lipid bilayer. The a-helices
are shown as cylinders (in cross section on the right), where the darker half-
circles represent the hydrophobic faces and the lighter half-circles represent
the hydrophilic faces. Also indicated are the apparent rate constants for each
process. The mathematical translation of this scheme is given by Eqs. 2, 3,
and 6–10. Binding of peptides creates a mass imbalance across the lipid
bilayer, which perturbs the membrane, possibly because of increase in local
curvature strain. This perturbation enhances the probability of a peptide
transiently inserting into the bilayer hydrophobic core and eventually
crossing the bilayer. In the bilayer-inserted state, the peptide catalyzes dye
efﬂux from the vesicle lumen; this state constitutes the apparent ‘pore’. As
peptide translocation is completed, the mass balance across the bilayer is
restored and the rate of efﬂux becomes very slow or eventually stops.
TABLE 1 Rate constants obtained from the ﬁts of experimental
kinetics to the model. The error is estimated from the ﬁts using
the linear regression (on-rates) or the variance in ﬁtting the
individual curves (all other constants), as described in Materials
and Methods
POPC POPS/POPC 2:8
kon (7.4 6 0.5) 3 10
4 M1s1 (2.6 6 0.08) 3 105 M1s1
koff 1.5 6 0.4 s
1 2.4 6 0.3 s1
k*ins 2.2 6 0.9 M
1s1 1.4 6 0.5 M1s1
kdins 0.40 6 0.15 s
1 0.26 6 0.05 s1
keﬂx 5.0 M
1s1 5.0 M1s1
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further evidence that tp10 exists predominantly in a mon-
omeric state in water. Because tp10-7mc (14 charge) has
one less positive charge than tp10 (15), we expect tp10 to
have even a greater tendency to be monomeric in aqueous
solutions. Cecropin A, for example, which has a smaller
charge density, 15/37 residues compared to tp10 with 15/
21 residues, is known to be monomeric in solution at a
concentration of 26 mM (28).
Kinetics of tp10 association with
phospholipid bilayers
The rates of association and dissociation of tp10-7mc with
phospholipid vesicles of POPC and POPS/POPC 2:8 were
measured at room temperature (;22oC) by monitoring the
rate of change in ﬂuorescence emission upon excitation of
the coumarin moiety at 350 nm by stopped-ﬂow ﬂuores-
cence. When tp10-7mc binds to phospholipid vesicles a
decrease in ﬂuorescence emission recorded through a 385-
long-pass ﬁlter is observed. This decrease in ﬂuorescence
intensity was used to monitor the association kinetics of
tp10-7mc with LUVs. In most cases the curves of ﬂuores-
cence intensity as a function of time were well ﬁt by a single
exponential decay (Fig. 4, A, POPC, and B, POPS/POPC
2:8), in accordance with Eq. 4,
MwðtÞ ¼ expðkapptÞ:
That the kinetics of association are exactly described by a
single exponential function further supports the assumption
that tp10 exists only as a monomer in aqueous buffer, pH 7.5,
at the peptide concentrations used in this work.
If a mixed population of monomers and oligomers existed,
it is very unlikely that they all would associate with the LUVs
with the same rate constants, so that a multiexponential decay
would probably be observed. The apparent rate constant,
FIGURE 3 Fluorescence of tp10-7mc as a function of its concentration in
aqueous solution. The experiment was performed by serial dilution of the
same solution. The inset shows the lower concentrations. Only perhaps at
;40 mM is there a slight deviation from the linear dependence.
FIGURE 4 Binding kinetics of tp10-7mc to LUVs of POPC (A and C) and
POPS/POPC 2:8 (B and D). The experimental decay of the ﬂuorescence of
tp10-7mc (7-methoxycoumarin chromophore) upon mixing with LUVs to a
ﬁnal lipid concentration of 80 mM is shown for POPC (A) and POPS/POPC
2:8 (B). The lines are single exponential ﬁts (Eq. 4). Note that the timescale
varies by a factor of 10 between the two types of vesicles. A plot of the
apparent values of the rate constant in experiments such as those in (A) and
(B), as a function of lipid concentration is shown for POPC (C) and POPS/
POPC 2:8 (D). The values of the slopes correspond to kon (Eq. 5), which are
indicated in Table 1. Two samples were examined for POPC and three
samples for POPS/POPC 2:8. For each sample, 3–5 curves were collected.
The means and standard deviations from all values are shown. The major
contribution to the variance arises from the different samples. When not
shown, the standard deviation is inside the point, but most of these cases
correspond to concentrations examined on the same sample.
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kapp, determined from the ﬁts is plotted as a function of the
lipid concentration in Fig. 4, C (POPC) and D (POPS/POPC
2:8) to obtain the on-rate constants (kon), according to Eq. 5.
The values obtained were kon¼ 7.43 104 M1s1 for POPC
and kon ¼ 2.63 105 M1s1 for POPS/POPC 2:8 (Table 1).
The latter is at the diffusion limit, unlike for POPC LUVs. In
the case of POPS:POPC 2:8 vesicles, the curves of ﬂuores-
cence intensity as a function of time were well ﬁt by a single
exponential decay for lipid concentrations .60 mM (Fig. 4
B). Below 60 mM, however, two exponentials were required
to ﬁt the curves. This may indicate that at low lipid con-
centration the peptide can partially discriminate between
bilayer areas rich in PS and binds to those areas faster.
However, analysis of the curves corresponding to 20–60 mM
lipid with a single exponential, which does not ﬁt very well,
or using the average of the apparent time constants (1/kapp)
obtained from a two-exponential ﬁt yields the same apparent
constant (kapp). Extrapolation of the straight lines to zero to
obtain koff has too much uncertainty because the intercept
occurs very close to the zero of the ordinate. Therefore, koff
was left as a free parameter and determined from the ﬁts to CF
efﬂux kinetics. There, a value of koff;2 s
1 was obtained for
both types of vesicles, POPC and POPS/POPC 2:8, within
experimental error. The value of koff;2 s
1 is actually what
is also obtained from the ﬁt of kapp versus lipid concentration
shown in Fig. 4 D.
Mechanism of dye release from vesicles:
all-or-none or graded?
The ANTS/DPX assay (25,26) was used to determine
whether the mode of dye release from lipid vesicles by
tp10 is ‘all-or-none’ or graded. In this assay, a ﬂuorophore,
ANTS, is encapsulated in the vesicles together with a
ﬂuorescence quencher, DPX. The quenching of ANTS ﬂuo-
rescence by DPX is a bimolecular process, therefore strongly
dependent on quencher concentration. Peptide interaction
with the vesicle causes the release of both ﬂuorophore and
quencher. The increased ANTS ﬂuorescence originating
from ANTS that escaped to the external medium is titrated by
adding additional quencher (DPX). The resulting ﬂuores-
cence is then only due to ANTS remaining in the vesicles,
where it is inaccessible to externally added DPX. If the
release were all-or-none, the degree of quenching in the
vesicles would be independent of the amount ANTS and
DPX released, since the vesicles would be either all empty or
completely intact. Only the intact vesicles would contribute
to the signal after the external quencher was added, and since
the DPX concentration in those intact vesicles does not
change, neither does the degree of quenching. However, if
the release is graded, only part of the ﬂuorophore is released
along with the quencher. The ﬂuorescence of ANTS remain-
ing in the vesicles increases because the quencher concen-
tration has also been lowered due to partial release. The degree
of quenching will then become a function of the amount of
ANTS and DPX released. As shown in Fig. 5, in the case of
tp10 the mode of release of vesicle contents is clearly graded.
The dashed line would correspond to all-or-none release. The
data in Fig. 5 were corrected for incomplete entrapment (26).
The solid line on the ﬁgure is Eq. 11 (25),
Qin ¼ Fi
F
max
i
¼ 1ð11Kd½DPX0ð1 foutÞaÞð11Ka½DPX0ð1 foutÞaÞ
;
(11)
where Fi and F
max
i are the ﬂuorescence intensities from the
vesicle interior with and without quencher (DPX), [DPX]0 is
the initial concentration encapsulated (5 mM was used for
both ANTS and DPX), fout is the ANTS fraction outside the
vesicles, Kd ¼ 50 M1 (25) is the dynamic quenching
constant, Ka ¼ 180 M1 (best ﬁt value) is the static
quenching constant, and a ¼ 0.55 (best ﬁt value) is the ratio
of the rates of release of DPX to ANTS, which indicates that
ANTS efﬂux is about twice as fast as DPX efﬂux.
Carboxyﬂuorescein efﬂux kinetics: forward
and reverse
Carboxyﬂuorescein is self-quenched at high concentrations.
Addition of peptide to phospholipid vesicles containing CF
encapsulated at high concentration causes dye efﬂux and
consequent increase in ﬂuorescence, arising mainly from the
dye that escaped from the vesicle lumen. A small effect
arising from relief of self-quenching of CF inside the vesicle
also occurs and was taken into account in this analysis (18).
The rate of CF ﬂuorescence increase is used to follow the
FIGURE 5 ANTS/DPX assay to determine the mechanism of release. The
quenching function inside, Qin ¼ Fi=Fmaxi , which is the ratio of ANTS
ﬂuorescence inside the vesicle in the presence (Fi) and absence (F
max
i ) of
quencher (DPX), is plotted against the ANTS fraction outside the vesicles,
fout, corrected for incomplete entrapment as described in Ladokhin et al.
(26). The horizontal line would be the result expected for an all-or-none
release. Clearly, release is graded. The solid line represents a ﬁt of Eq. 11 to
the data points, which are pooled from three independent samples. The ﬁt
parameters are Kd ¼ 50 M1, Ka ¼ 180 M1, and a ¼ 0.55.
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kinetics of dye efﬂux. Tp10 at a ﬁnal concentration of 0.5
mM was mixed with LUVs, varying the lipid concentration
between 20 and 200 mM (after mixing), and the kinetics of
dye efﬂux were monitored. The maximum possible ﬂuores-
cence levels were determined by adding the detergent Triton
X-100 to the vesicle suspension at a concentration of 1%,
which dissolves the vesicles.
The kinetics of dye release obtained by adding the peptides
from aqueous solution are not very sensitive to the backward
rates, that is, the rate constants in the direction of the reaction
written as the reverse of the scheme shown in Fig. 2, such as
the off-rates from the vesicles. To better determine those
rates, a ‘reverse experiment’ was carried out: the efﬂux kinetics
were measured after tp10 was prebound for 1 h to empty
(donor) vesicles, which were mixed in the stopped-ﬂow with
acceptor vesicles containing CF. Now, tp10 must dissociate
from the donor vesicles back into water before being able to
bind to acceptor vesicles and induce CF release. Both types of
vesicles (donors and acceptors) had the same lipid compo-
sition. These experiments were performed both with pure
POPC (Fig. 6, A, forward, and B, reverse) and with POPS/
POPC 2:8 vesicles (Fig. 7, A, forward, and B, reverse). We
note, ﬁrst, that for the same ﬁnal lipid concentration (50 mM)
the timescale for dye release in the reverse reaction is only
;103 longer than in the forward reaction, indicating that
tp10 readily desorbs from the donor vesicles and equilibrates
over the entire vesicle population. Second, the difference
between the kinetics of efﬂux from POPS/POPC 2:8 and pure
POPC is not very signiﬁcant. This is true despite the 15
charge carried by tp10 at pH 7.5, which is expected to lead to
stronger binding to the vesicles containing the anionic lipid
POPS—as indeed it does, which is shown by a kon ;103
larger than for POPC LUVs. In both cases, but more pro-
nounced for POPS/POPC 2:8 vesicles, the kinetics of CF
efﬂux and the ﬁnal amount of dye released depend on lipid
concentration. The lines shown in Figs. 6 and 7 are the best
global ﬁts of the theoretical model (Eqs. 2, 3, and 6–11) to the
two data sets. Forward and reverse kinetics for POPC are
described by one set of parameters and the same is true for
POPS/POPC2:8, with parameters that are only slightly differ-
ent from those used for POPC, except for the on-rate constant.
These ﬁts are analyzed in more detail in the next section.
Analysis of efﬂux kinetics
The on-rate constants for tp10 association with lipid vesicles
were determined from the binding kinetics and ﬁxed in
the remaining ﬁts. For the other parameters, separately for
POPC and POPS/POPC 2:8, the best global ﬁt was sought
that would describe both the lipid concentration dependence
of the forward CF-efﬂux kinetics (Figs. 6 A and 7 A) and the
reverse kinetics (Figs. 6 B and 7 B). The values that yielded
the best ﬁts for the model proposed (Fig. 2) are listed in
Table 1. For the deﬁnition of the rate constants, please refer
to Fig. 2 and Eqs. 6–11, which describe the kinetic model.
Other models were also tried. Models that require dimeriza-
tion or tetramerization on the membrane, with the dimer or
tetramer as the state that translocates across the bilayer, were
able to ﬁt quite well the kinetics of tp10 interaction with
vesicles of POPS/POPC 2:8. However, though the dimer
FIGURE 6 (A) Kinetics of carboxyﬂuorescein efﬂux from POPC LUVs
after tp10 (0.5 mM) addition. The gray curves, from top (fastest) to bottom
(slowest) are the experimental data for 20, 30, 50, 100, and 200 mM lipid.
The data were normalized by the Triton X-100 release levels. Each curve is
the average of a total of 5–9 experiments performed on 2 or 3 independent
samples. The thin black lines represent the best ﬁt of the theoretical kinetic
model to the experimental data, allowing for a 50% variation in each
parameter relative to the best simultaneous ﬁt. The values of the best global
ﬁt are indicated in Table 1. Because Triton X-100 release levels obtained
with this peptide have shown a signiﬁcant variation between different
preparations, an amplitude factor of 0.75–1.2 was included in the ﬁts. For the
ﬁts shown, the amplitude factors are 0.83, 0.97, 1.2, 1.2, and 1.2 for 20, 30,
50, 100, and 200 mM lipid, respectively. (B) Reverse experiment of carboxy-
ﬂuorescein efﬂux from POPC LUVs induced by tp10. Donor vesicles were
prepared by preincubating 1 mM tp10 with 60 mM POPC (empty LUVs) for
1 h, and the kinetics were followed by mixing with 40-mM POPC acceptor
vesicles (containing dye) so that the ﬁnal concentration of POPC was 50 mM
and the ﬁnal tp10 concentration was 0.5 mM in the stopped-ﬂow experiment.
The efﬂux fraction is normalized to the Triton X-100 release level. The
amplitude factor was 0.92. The gray curve represents the experimental data,
and the thin black line is the best (global) ﬁt, with the same parameters as in
(A), within the allowed variation (Table 1). Please note that the timescales
are different in panels (A) and (B).
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model can ﬁt the POPC data, it does so worse than the
monomer model. We cannot, of course, discard the possi-
bility that the oligomerization state of the peptide species that
crosses the bilayer is different in POPC and POPS/POPC
2:8. In any case, overall none of these models is better than
the one involving only monomers, which is the simplest.
Another model tried was a simple perturbation of the membrane
by surface-associated peptides, but this did not yield good
ﬁts. For the simple model proposed, which involves only
monomers, it is possible to obtain excellent ﬁts for each
curve. The requirement that the model ﬁt the reverse exper-
iment efﬂux curve as well renders the ﬁts a little worse. This
indicates that perhaps a minor effect has not entirely been
incorporated into the model, but overall it seems that it
captures the essence of the interaction of tp10 with phos-
pholipid vesicles. We note that only three rate constants are
adjusted by ﬁtting to the CF efﬂux curves. The fourth constant
(keﬂx) was ﬁxed because there is a strong correlation between
keﬂx and kdins. This correlation arises because it is the inserted
species that catalyzes efﬂux, so that the shorter its lifetime
the smaller the amount of dye that can escape while the
peptide is inserted. Therefore, for sufﬁciently large values of
these two parameters only their ratio, keﬂx/kdins, is signiﬁcant.
Then, according to the model, what is the reason for the
slight difference in CF efﬂux from POPC and POPS/POPC
2:8? The answer can be obtained by inspecting the behavior
of the various tp10 states calculated as a function of time, for
the same lipid concentration (20 mM) in POPC (solid lines)
and POPS/POPC (dashed lines), which is shown in Fig. 8.
The binding of tp10 to POPC vesicles occurs more slowly
FIGURE 7 Same as for Fig. 6, but for vesicles of POPS/POPC 2:8. (A) For-
ward reaction. The peptide concentration is 0.5 mM and the lipid concen-
trations are 20, 30, 50, and 100mM. The amplitude factors are 0.97, 0.98, 1.2,
and 1.2, in the same order. (B) Reverse experiment. The amplitude factor is
0.75. Please note that the timescales are different in panels (A) and (B).
FIGURE 8 The fraction of the different peptide states as a function of time,
calculated from the ﬁts for 20 mM POPC (solid lines) and 20 mM POPS/
POPC 2:8 (dashed lines). The tp10 concentration is 0.5 mM in both cases.
(A) shows the fraction in aqueous solution; (B) shows the fraction of tp10
bound to the outer leaﬂet (decreasing curves) and to the inner leaﬂet
(increasing curves) of the bilayer; and (C) shows the fraction of tp10 inserted
into the bilayer. The latter curves should be viewed only qualitatively
because of the high degree of correlation between kdins and keﬂx, which can
signiﬁcantly alter the time and amplitude of the inserted fractions.
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than to POPS/POPC vesicles (Fig. 8 A), which is a con-
sequence of the smaller kon in the former. In both cases, the
efﬂux tends to zero as the concentrations of tp10 bound to the
outer and inner leaﬂets of the bilayer approach each other
(B). The transient of the tp10 concentration in the bilayer (C)
has a larger amplitude in POPS/POPC 2:8. This is the state
that ‘catalyzes’ efﬂux; therefore, dye release is a bit faster in
POPS/POPC 2:8 than in pure POPC.
DISCUSSION
A detailed investigation of the mechanism of the interac-
tion between the CPP tp10 and phospholipid vesicles was
performed. The main ﬁnding is that the kinetics of peptide
binding to lipid vesicles and the peptide-induced efﬂux of CF
encapsulated in the vesicles are entirely consistent with a
very simple model (Fig. 2): ﬁrst, the peptides bind to the
outer surface of the lipid vesicle and their accumulation
creates a mass imbalance across the bilayer, which strains the
membrane; second, to relieve that perturbation, tp10 mon-
omers translocate across to the inner surface of the membrane.
The presence of peptide in the bilayer renders it permeable to
the encapsulated dye, which leaks out, concomitant with
peptide translocation. When the concentration of tp10 bound
to both leaﬂets of the bilayer is equal, the efﬂux essentially
stops because the mass imbalance strain is relieved and the
membrane is no longer perturbed.
The membrane charge plays a signiﬁcant role in the rates
of peptide binding to the membrane surface. As expected, the
on-rate to vesicles with a negative charge (POPS/POPC 2:8)
is fast, with kon ¼ 2.6 3 105 M1s1, essentially diffusion
limited, and almost an order of magnitude larger than for
zwitterionic vesicles (POPC), with kon ¼ 7.43 104 M1s1.
This, however, is not of much consequence for dye efﬂux,
which occurs at about the same rate from both types of ves-
icles, because more important than the on-rate is the duration
of the membrane perturbation, which is only slightly larger
when POPS is present (Fig. 8 C).
Tp10 induces dye release in a graded manner. This means
that if, at a certain point in time, the mean dye content of the
vesicle population is 50% of the initial, all vesicles have
released ;50% of their content. The alternative would be an
all-or-none mechanism, in which a 50% dye release by the
vesicle population would arise from 50% of the vesicles
having released all their contents whereas the other 50%
released none. The importance of establishing the mechanism
of release is that it allows certain models to be discarded. For
example, permanent channels, such as the barrel-stave model
(29), necessarily produce all-or-nonemechanisms and are not
consistent with the data for tp10. On the other hand, both the
toroidal hole (30,31) and the sinking raft models (17,18) are
consistent with a graded mechanism of dye release. Another
important model is the carpet model (32,33), in which the
peptides ﬁrst bind to the membrane, oriented parallel to the
surface, forming a carpet. At some critical threshold, they
cause the vesicle to disintegrate (micellize), releasing all its
contents at once. In this extreme case the model is only
compatible with all-or-none dye release. Clearly, the action of
tp10 is not consistent with this extreme case of the carpet
model: there is no threshold, the release is graded, and the
concentration of peptide on the vesicle surface in all our
experiments is much smaller (peptide/lipid ratio ;1:100)
than required to form a complete carpet. However, the carpet
model includes the possibility that, at lower peptide surface
concentrations, transient pores may form, allowing for graded
release of vesicle contents. This may require a high local
peptide surface concentration, but not necessarily a coating of
the membrane. The model proposed here for the mechanism
of tp10 is consistent with this view of the carpet model.
Namely, bound peptide is always oriented parallel to the
membrane surface, there are no speciﬁc tp10 aggregates
formed, and dye efﬂux occurs because of membrane pertur-
bation and not because of a hole ‘punched’ in the bilayer.
Another way of viewing the model presented here is as a
limiting case of the sinking raft model, where the ‘raft’ has
only one ‘log’.
Most a-helical, amphipathic peptides examined to date are
oriented parallel to the membrane surface upon binding, at
least at low peptide/lipid ratios (34). This is true, for example,
for cecropin A (35,36), LL-37 (37,38), the synthetic antimi-
crobial peptides MSI-78 and MSI-594, derived from
magainin-2 and melittin (39), magainin-2 (40,41), and
cecropin-melittin hybrids (42). Some authors have proposed
that the peptides insert perpendicular to the bilayer at higher
peptide concentrations (30,43), but in most cases this has not
been observed. What seems to be emerging is the view that
the essential aspect of the activity of these peptides is
the perturbation of the membrane, which leads directly to the
increase inmembrane permeability, for example, to dyes. The
notion that large pores are required to achieve this perme-
ability increase is, in our view, incorrect. The concept of large
pores developed naturally as an analogy to ion channels (29)
but pictured the membrane as a rigid hydrophobic slab into
which it was necessary to make a hole to allow water-soluble
compounds through. What is missing in that view is the
realization that the lipid bilayer properties are not well
approximated by an inert hydrophobic slab (23) and that the
lipid molecules will adapt to the changes caused by a mass
imbalance in the form of bound amphipathic peptides. The
concept presented here—that monomers of a 21-residue,
amphipathic peptide can permeate the bilayer—may appear
unexpected at ﬁrst. It is, however, well supported by molec-
ular dynamics simulations (20) and thermodynamic analysis
using the hydrophobicity scales of White and Wimley (23)
for transfer of peptides from water to the bilayer interface and
to its interior (mimicked by n-octanol), as demonstrated below.
Recent molecular dynamics simulations (20,21) using a
coarse-grained representation of lipids and amphipathic anti-
microbial polymers indicate that these antimicrobials bind
ﬁrst to the membrane and then cooperatively perturb the
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bilayer. As a consequence, the antimicrobials translocate
across and water molecules permeate through the bilayer
(20). A similar result is shown by all-atom molecular
dynamics simulations of a deletion mutant of magainin-2
(22), consistent with what we propose. In our model, the rate
of peptide insertion into the hydrophobic core of the bilayer
is zero if the membrane is not perturbed. This is, of course,
an approximation. But when enough peptides bind to the
outer surface of the lipid vesicle, the rate constant for
insertion—that is, partition into the hydrophobic core of the
bilayer—increases proportionally to the difference in the
concentration of peptide bound to the outer and inner leaﬂets
of the membrane, and tp10 readily crosses the bilayer.
Finally, a strong argument in support of the simple model
proposed comes from the analysis of the thermodynamics of
tp10 association with the membrane and insertion into the
bilayer core using the approach of White and Wimley (23).
Referring to Fig. 9, let us decompose the process of peptide
insertion into the bilayer hydrophobic core into three steps:
ﬁrst, tp10 transfer from water to the bilayer interface; second,
folding of tp10 into a helical structure; and third, transfer of
tp10 into the bilayer core. Now, using the interfacial scale of
White and Wimley (23), the transfer to the interface
corresponds to a Gibbs free energy of DGo ¼ 1.84 kcal/
mol. Helix formation on the membrane/water interface
corresponds to DGo ¼ 6.0 kcal/mol for a 70% helical
structure, which is a typical value for this type of peptide.
Transfer of the helix from the surface to the interior can be
obtained by completing the thermodynamic cycle with the
direct transfer of the helix to the bilayer core. The latter is
calculated using the water-octanol hydrophobicity scale (23)
and corresponds to DGo ¼ 111.4 kcal/mol. Therefore,
transfer of tp10 from the membrane surface to its hydro-
phobic core corresponds to DGo ¼ 119.8 kcal/mol. This
value should be close to the activation energy (DGz) for
bilayer insertion of tp10 from a surface-associated state.
Using 19.8 kcal/mol in the expression for the insertion
rate constant, k ¼ (kBT/h) exp(DGz/kBT), where kB is
Boltzmann’s constant, h is Planck’s constant, and T is
temperature, a value of k ¼ 0.013 s1 is obtained. This
corresponds to a characteristic time 1/k ;80 s, which is not
long and is well within the time frame of the experiments
reported here. To compare exactly this value with our
insertion rate constant, onemust use Eq. 10. Inspection of Fig.
8 B shows that the difference between the fraction of tp10
states bound to the outer and inner leaﬂets of the bilayer varies
over the course of the reaction between;0.8 at the beginning
and;0 at the end. Using;0.5, a value close to the beginning,
in Eq. 10, together with the peptide and lipid concentrations
(0.5 and 20mM), and k*ins 2M1s1 (Table 1), one obtains
kins;2 s
1. This is only 160 times faster than calculated in the
absence of any membrane perturbation from the White and
Wimley (23) hydrophobicity scales. If a perturbation of the
membrane by DG ¼ 1RT ln(160) ¼ 3 kcal/mol at room
temperature is postulated, the calculated rate constant
becomes equivalent to the value obtained from the ﬁt. This
is a small, entirely plausible perturbation arising from the
mass imbalance across the bilayer, caused by peptide binding.
In conclusion, we have proposed a simple model for the
mechanism of the interaction of tp10 with lipid vesicles,
which involves translocation of the peptide across the
membrane. This is not necessarily the only possible model;
but it is the simplest model that is entirely consistent with the
experimental kinetic data and with the thermodynamics of
transfer of tp10 from water to the bilayer interface and to its
hydrophobic interior.
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